HOB Biotech Group Corp.,Ltd

Rachunek Zysków i Strat





Przychody TTM (mln): 398
EBIT TTM (mln): 45
index 0 1 2 3 4 5 6 7 8
Rok finansowy 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 112 146 201 259 222 318 320 394 402
Przychód Δ r/r 0.0% 31.1% 37.7% 28.6% -14.4% 43.2% 0.8% 23.1% 2.0%
Marża brutto 65.6% 69.7% 70.6% 68.1% 65.6% 69.0% 63.1% 62.1% 63.9%
EBIT (mln) 3 25 49 70 65 98 48 56 41
EBIT Δ r/r 0.0% 681.5% 100.0% 42.5% -7.1% 49.8% -51.2% 17.4% -25.9%
EBIT (%) 2.8% 16.8% 24.4% 27.0% 29.3% 30.7% 14.8% 14.2% 10.3%
Koszty finansowe (mln) 2 2 2 1 2 1 2 3 3
EBITDA (mln) 11 34 66 88 83 125 81 99 89
EBITDA(%) 10.2% 23.5% 32.7% 34.1% 37.3% 39.4% 25.2% 25.0% 22.1%
Podatek (mln) -0 3 7 10 8 13 5 9 4
Zysk Netto (mln) 4 21 40 64 57 86 42 47 37
Zysk netto Δ r/r 0.0% 392.6% 88.0% 59.0% -11.3% 52.2% -51.7% 13.6% -22.2%
Zysk netto (%) 3.9% 14.6% 19.9% 24.6% 25.5% 27.1% 13.0% 12.0% 9.1%
EPS 0.0954 0.47 0.88 1.01 0.9 1.37 0.66 0.75 0.59
EPS (rozwodnione) 0.0954 0.47 0.88 1.01 0.9 1.37 0.66 0.74 0.59
Ilośc akcji (mln) 45 45 46 63 63 63 63 63 62
Ważona ilośc akcji (mln) 45 45 46 63 63 63 63 64 63
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY